UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 14, 2012

 

ENTREMED, INC.

(Exact Name of Registrant as Specified in its Charter)

 

DELAWARE
(State or other jurisdiction  of
incorporation or organization)
0-20713
(Commission File Number)

58-1959440
(IRS Employer Identification 
No.)

 

9640 Medical Center Drive

Rockville, Maryland

______________________

(Address of principal executive offices)

 

20850

____________________

(Zip Code)

 

(240) 864-2600

_____________________

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 2.02 Results of Operations and Financial Condition.

 

On November 14, 2012, EntreMed, Inc. (the “Company”) issued a press release reporting its financial results for the three and nine month periods ending September 30, 2012. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information on this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)   Exhibits
     
99.1   Press Release of EntreMed, Inc., dated November 14, 2012

 

 
 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ENTREMED, INC.
   
  /s/ Sara B. Capitelli
  Sara B. Capitelli
  Vice President, Finance and Principal Accounting Officer

 

Date: November 14, 2012

 

 
 

 

EXHIBIT INDEX

 

Exhibit Number   Description of Document
     
99.1   Press Release of EntreMed, Inc., dated November 14, 2012